The role of HMG-CoA reductase inhibitors in cardiovascular risk reduction
Guidelines on CHD prevention have placed emphasis on identifying and treating suitable individuals with statin therapy and have set cholesterol goals to be attained. Absolute risk is based on modifiable and non-modifiable factors including age. By failing to initiate statin treatment in high risk p...
Main Author: | McIntyre, Christine |
---|---|
Published: |
University of Aberdeen
2004
|
Subjects: | |
Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.415483 |
Similar Items
-
A study of aspirin resistance in patients with cardiovascular disease
by: Muir, Alison Rachel
Published: (2008) -
The effect of HMG CoA reductase inhibition on platelet and vascular reactivity in hypercholesterolaemia
by: Hughes, SineÌad Marie-TheÌreÌ€se
Published: (2006) -
Pleiotropic effects of the HMG-CoA reductase inhibitors
by: Mihos CG, et al.
Published: (2011-04-01) -
The discovery and development of HMG-CoA reductase inhibitors.
by: A Endo
Published: (1992-11-01) -
Butyrate and HMG-CoA reductase inhibitors in ulcerative colitis
by: McKay, Damian
Published: (2010)